Lactobacillus casei FG12
Lactobacillus casei FG12 is a novel probiotic strain with a single indexed publication, a 2025 rat study examining antioxidant activity and potential effects in a chemically induced cancer model. Animal studies using chemical carcinogens are highly controlled experimental systems that do not establish efficacy or safety in humans; results from such models are preliminary and exploratory only. No human clinical data were identified for this strain. The broader L. casei species has a well-established probiotic research history, but findings cannot be extrapolated to this strain without dedicated human research. FG12 should be considered a very early-stage research organism.
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
1 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.